WEIGHT LOSS COMPARISON

Weight-loss injections vs.
oral & sublingual options.

Compounded weekly semaglutide ($199/month) and tirzepatide ($249/month) injections use the route studied in large clinical trials. Sublingual semaglutide ($179/month) and oral tirzepatide ($249/month) avoid needles and are usually taken daily, but absorption under the tongue or by mouth is uncertain and human studies of the compounded oral forms are limited.

Compare site-published facts below, or view weight loss options and all plan pricing. A licensed provider decides whether any treatment is appropriate.

SIDE-BY-SIDE COMPARISON

Compounded Injections (Semaglutide / Tirzepatide) vs. Oral & Sublingual (Semaglutide Sublingual / Tirzepatide Oral)

Side-by-side comparison of compounded weight-loss injections vs oral and sublingual forms at ABS Health
FeatureCompounded Injections (Semaglutide / Tirzepatide)Oral & Sublingual (Semaglutide Sublingual / Tirzepatide Oral)
FormatCompounded injectable solution measured with a supplied syringeSemaglutide Sublingual: liquid or dissolving prep held under the tongue. Tirzepatide Oral: compounded preparation taken by mouth.
Dosing schedule (as stated)Weekly injection on the schedule printed on your prescriptionUsually once daily per prescription label (sublingual held under the tongue before swallowing; avoid food/drink for label period; no standard published oral tirzepatide dosing)
Starting priceSemaglutide Injection: $199/month; Tirzepatide Injection: $249/monthSemaglutide Sublingual: $179/month; Tirzepatide Oral: $249/month
Plan optionsMonthly, 3 months ($499 / $649), 6 months ($899 / $1,199), 12 months ($1,399 / $1,999)Monthly, 3 months ($483 / $672), 6 months ($912 / $1,272)
Evidence & absorption (as stated)Weekly injections are the form studied in the large clinical trials and have more published evidence.Absorption under the tongue or by mouth may be lower, uncertain or more variable; studies of compounded oral forms in people are limited or lacking.
Who it may suit (as stated)Adults comfortable with weekly injections who want the form with broader published clinical trial evidenceAdults seeking medical weight management who strongly prefer to avoid needles and accept that evidence is limited
FDA / compounding statusCompounded medications are not FDA-approved.Compounded medications are not FDA-approved (no FDA-approved sublingual semaglutide or oral tirzepatide exists).
Switching formsDoses are not interchangeable across forms; switching requires a new prescription and directions.Doses are not interchangeable across forms; do not combine with other GLP-1 medicines.

Prescription required. A licensed provider reviews your online visit and decides whether treatment is appropriate. Compounded medications are not FDA-approved.

How injections and oral/sublingual forms differ

Both routes deliver GLP-1 or GIP/GLP-1 active ingredients, but the delivery method changes how reliably the medicine is absorbed. As published on ABS Health’s semaglutide sublingual and tirzepatide oral pages, weekly semaglutide injection and tirzepatide injection are the forms studied in the large clinical trials.

Peptide medicines are partly broken down in the digestive tract, and absorption under the tongue or by mouth may be lower or more variable. Oral and sublingual options suit adults who strongly prefer to avoid needles and accept that clinical evidence for compounded oral forms is limited.

Dosing schedules and plan pricing

Injections are given weekly, with 1-, 3-, 6- and 12-month plans ($199 to $1,399 for semaglutide; $249 to $1,999 for tirzepatide). Sublingual semaglutide and oral tirzepatide are usually taken once daily according to the pharmacy label, with Monthly, 3-month and 6-month plans ($179/$483/$912 for semaglutide sublingual; $249/$672/$1,272 for tirzepatide oral). See the pricing page for full monthly equivalents.

Also review Tirzepatide Injection and Tirzepatide Oral directly if you are comparing the dual GIP/GLP-1 options.

Switching, safety and clinical review

You cannot swap directly between an injection and an oral or sublingual form: the doses are not interchangeable, so switching requires a new provider evaluation and new directions. The same warnings apply to both routes, including common GI side effects and the animal-study thyroid C-cell tumor warning (do not use with personal or family medullary thyroid carcinoma or MEN 2).

How your care works.

01 / ONLINE INTAKE

Your health, your goals.

Choose a plan, then share your medical history, current medications, allergies and goals in your online visit.

02 / CLINICAL REVIEW

A decision guided by your health.

A licensed provider reviews your information. Further questions, a virtual consultation or testing may be needed, and a prescription is not guaranteed.

03 / TREATMENT & FOLLOW-UP

Stay connected to your care.

If prescribed, your medication is filled by a partner pharmacy and delivered where available. Use your account for messages, order updates and follow-ups.

Questions about Weight Loss Injection vs Oral and Sublingual

No. Weekly semaglutide and tirzepatide injections are the forms studied in large clinical trials. Published studies on compounded sublingual semaglutide and oral tirzepatide in people are limited or lacking.

Injections are typically taken once weekly, while sublingual semaglutide and oral tirzepatide are usually taken once daily according to the pharmacy label.

Only with your provider. Doses are not interchangeable across forms, so switching requires a new prescription and instructions.

Compounded semaglutide injection starts at $199/month and sublingual semaglutide starts at $179/month. Both compounded tirzepatide injection and oral tirzepatide start at $249/month. Injections offer 1-, 3-, 6- and 12-month plans; oral and sublingual offer 1-, 3- and 6-month plans.

No. Compounded medications are not FDA-approved, and there is no FDA-approved sublingual semaglutide or oral tirzepatide product.